Active — Not RecruitingNot Applicable

Prospective Multiethnic Validation of the Behçet's Syndrome Overall Damage Index (BODI)

Italy970 participantsStarted 2021-07-23

Plain-language summary

PROBE is an observational multicenter cohort study, consisting of a cross-sectional and a 5-years prospective phase, designed to target the major study objectives, such as testing the comprehensiveness of the Behçet's syndrome Overall Damage Index (BODI) in a wide and ethnically heterogeneous cohort of Behçet's syndrome patients, and investigating how damage assessed by the BODI correlates with other major long-term disease outcomes (5-years mortality and hospitalization rates).

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of BS according to ICBD or ISG criteria. Exclusion Criteria: * Subjects unable or unwilling to make themselves available for the duration of the study and/or are unwilling to follow interval visits.

What they're measuring

5-years mortality rate

Timeframe: 5 years

5-years hospitalization rate

Timeframe: 5 years

Trial details

NCT IDNCT07073261

SponsorUniversity of Cagliari

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-12-30

View on ClinicalTrials.gov More Behçet's Syndrome (BS) trials